Conditions Causing Low White Blood Cells and Low Platelets with Normal Hemoglobin/Hematocrit
The combination of leukopenia and thrombocytopenia with preserved hemoglobin and hematocrit should prompt immediate consideration of hypocellular myelodysplastic syndrome (H-MDS), hypocellular acute myeloid leukemia (H-AML), viral infections (particularly parvovirus B19), and drug-induced cytopenias as the primary differential diagnoses.
Primary Hematologic Malignancies
Hypocellular MDS and hypocellular AML are critical diagnoses that must be excluded first, as they account for 10-15% of myeloid malignancies and can present with isolated leukopenia and thrombocytopenia while hemoglobin remains initially preserved 1. These conditions predominantly affect the elderly and require bone marrow biopsy for definitive diagnosis, as aspirate smears alone are insufficient due to paucicellularity 1.
Key Diagnostic Approach for H-MDS/H-AML:
- Peripheral blood film: Count at least 100 cells, enumerate granulocyte dysplasia, assess for blasts 1
- Bone marrow aspirate: Perform 500-cell differential if possible, examine for dysplasia across all lineages 1
- Bone marrow biopsy: Essential for assessing cellularity and presence of abnormal localization of immature precursors (ALIP) with CD34/CD117/myeloperoxidase immunostains 1
The critical distinction is that H-MDS typically presents as refractory anemia with minimal dysplasia, making it challenging to differentiate from aplastic anemia without comprehensive bone marrow evaluation 1.
Infectious Causes
Parvovirus B19 infection is a well-documented cause of isolated leukopenia and thrombocytopenia with normal or near-normal hemoglobin in healthy adults 2, 3. This should be strongly considered when:
- Patient presents with common cold-like symptoms or febrile illness
- Erythema infectiosum is prevalent in the community
- WBC counts range 1,000-2,000/μL with neutropenia
- Platelet counts drop to 45,000-108,000/μL
- Hemoglobin remains 9.4-14.9 g/dL 3
Diagnosis: Check parvovirus B19-specific IgM antibodies or serum viral DNA by PCR. Most cases resolve spontaneously within weeks to months 2, 3.
Dengue infection also causes this pattern, with leukopenia present in 64.68% and thrombocytopenia in 40.48% of patients, and both correlate with disease severity 4. Consider in appropriate geographic/travel contexts.
Chronic Liver Disease
Hepatitis C virus infection causes leukopenia (39.3% prevalence) and thrombocytopenia (67.9% prevalence) through direct hematopoietic suppression, not just hypersplenism 5. This occurs in:
- Hemodialysis patients with HCV
- Patients with hepatitis C-induced cirrhosis (50% leukopenia, 81.6% thrombocytopenia) 5
The mechanism appears to be direct viral effect on bone marrow rather than solely splenic sequestration, as the pattern occurs even before cirrhosis develops 5.
Hypersplenism
While hypersplenism classically causes pancytopenia, selective leukopenia and thrombocytopenia with preserved hemoglobin can occur in early or partial hypersplenism 6. This is particularly relevant in:
- Hemoglobin SC disease (where auto-splenectomy is incomplete)
- Portal hypertension from any cause
- Chronic infections causing splenomegaly
Drug-Induced Cytopenias
Medication-induced bone marrow suppression must be systematically reviewed 7, 8. Common culprits include:
- Chemotherapeutic agents
- Immunosuppressants
- Amphotericin B (causes severe leukopenia in 20.6% and severe thrombocytopenia in 10.6%) 8
- Anticonvulsants
- Antibiotics (particularly sulfonamides)
Critical Pitfalls to Avoid
Do not assume aplastic anemia without bone marrow biopsy - H-MDS and H-AML can mimic aplastic anemia clinically but require different treatment approaches 1
Do not overlook viral serologies - Parvovirus B19 testing is justified even with minimal anemia when leukopenia/thrombocytopenia are present, especially during community outbreaks 3
Do not attribute all cytopenias to hypersplenism - HCV causes direct marrow suppression independent of splenic sequestration 5
Monitor for progression - In lower-risk MDS, neutropenia <1,500/mm³ occurs in only 7% and platelets <50,000/mm³ in approximately 30%, but these can herald disease progression 7
Algorithmic Approach
- Immediate: Review all medications, obtain viral serologies (parvovirus B19 IgM, HCV antibody, dengue if appropriate)
- Within 48-72 hours: Peripheral blood smear examination for dysplasia and blasts
- If no clear infectious/drug cause identified: Proceed to bone marrow aspiration and biopsy with immunohistochemistry, flow cytometry, and cytogenetics 1
- If hepatitis suspected: Check liver function tests and consider abdominal ultrasound for splenomegaly
- Monitor closely: Serial CBCs to assess trajectory - spontaneous resolution suggests viral etiology, progressive worsening suggests malignancy